Early discontinuation of empirical antibacterial therapy in febrile neutropenia: the ANTIBIOSTOP study.

Lenaïg Le ClechJean-Philippe TalarminMarie-Anne CouturierJean-Christophe IanottoChristophe NicolRonan Le CallochStéphanie Dos SantosPascal HutinDidier TandéVirginie CoguletChristian BerthouGaëlle Guillerm

Published in: Infectious diseases (London, England) (2018)

These results suggest that early discontinuation of empirical antibiotics in FUO is safe for afebrile neutropenic patients.

Keyphrases

end stage renal disease
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
stem cells
bone marrow
mesenchymal stem cells
chemotherapy induced
smoking cessation
wound healing